MetLife Investment Management’s Kyverna Therapeutics KYTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,693	Closed	-$35.2K	–	2917
2024 Q2	$35.2K	Buy	+4,693	New	+$35.2K	﹤0.01%	2824